Therapeutic peptides
CA 1296486 C · Owner: Coy, David H. · Inventors: Coy, David H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
412-1521, Abstract of the Disclosure, A decapeptide of the formula: Ac-A1 -A2-D-Trp-Ser-Tyr-A3-A4-A5-A6-, A7-NH2 wherein each A1 and A2 independently, is, D-Trp, D- .beta. -Nal or D-p-X-Phe, wherein X is a halogen, or CH3; A3 is D- .beta. -Nal D-Trp, D-Lys, D-Arg, D-homo-Arg, D-diethyl-homo-Arg or D-p-X-Phe, wherein X, is a halogen or CH3; A4 is Phe Tyr, pentafluoro-, Phe, Trp, .beta. -Nal or p-X-Phe, wherein X is a halogen or, CH3; A5 is Arg or Lys A6 is Pro or hydroxy-Pro; and A7 is Gly or D-Ala; or a pharmaceutically acceptable salt thereof. These compounds find use in inhibiting the release of LH-RH and, since they exhibit a long duration of activity, minimize both the amountand the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 25, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 25, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.